Synthetic chemistry-led creation of a difluorinated biaryl ether non-nucleoside reverse transcriptase inhibitor.

Abstract excerpt

In the process of developing a series of novel, fluorinated biaryl ether NNRTIs, we fortuitously discovered derivative 20, which possesses excellent potency against both wild-type and clinically relevant mutations of the reverse transcriptase enzyme.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chemistry, Pharmaceutical
• Share to Molecular Structure
• Share to Mutation